Renaissance Technologies LLC Decreases Holdings in Haleon plc (NYSE:HLN)

Renaissance Technologies LLC decreased its holdings in Haleon plc (NYSE:HLN - Free Report) by 44.0% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,300,699 shares of the company's stock after selling 1,021,525 shares during the quarter. Renaissance Technologies LLC's holdings in Haleon were worth $10,744,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in HLN. Cardinal Capital Management increased its holdings in shares of Haleon by 2.5% during the second quarter. Cardinal Capital Management now owns 46,231 shares of the company's stock valued at $382,000 after acquiring an additional 1,140 shares in the last quarter. Endowment Wealth Management Inc. raised its holdings in shares of Haleon by 9.9% in the second quarter. Endowment Wealth Management Inc. now owns 12,867 shares of the company's stock worth $106,000 after buying an additional 1,161 shares during the last quarter. Portside Wealth Group LLC lifted its stake in shares of Haleon by 2.7% during the second quarter. Portside Wealth Group LLC now owns 44,985 shares of the company's stock worth $372,000 after buying an additional 1,182 shares during the period. Lester Murray Antman dba SimplyRich grew its holdings in shares of Haleon by 2.9% during the second quarter. Lester Murray Antman dba SimplyRich now owns 45,519 shares of the company's stock valued at $375,000 after buying an additional 1,301 shares during the last quarter. Finally, Resonant Capital Advisors LLC increased its position in shares of Haleon by 7.2% in the 2nd quarter. Resonant Capital Advisors LLC now owns 19,846 shares of the company's stock valued at $164,000 after acquiring an additional 1,334 shares during the period. 6.67% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on the company. Berenberg Bank started coverage on Haleon in a report on Tuesday, August 6th. They issued a "buy" rating on the stock. The Goldman Sachs Group lowered Haleon from a "buy" rating to a "neutral" rating in a research note on Tuesday, August 6th. Finally, Morgan Stanley increased their price target on shares of Haleon from $9.90 to $10.95 and gave the company an "overweight" rating in a research note on Friday. One analyst has rated the stock with a hold rating and four have issued a buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $10.95.

Haleon Trading Up 0.5 %

Haleon stock traded up $0.05 during midday trading on Tuesday, reaching $10.68. 3,193,651 shares of the stock traded hands, compared to its average volume of 4,925,421. The firm has a market cap of $48.77 billion, a PE ratio of 35.45, a price-to-earnings-growth ratio of 3.10 and a beta of 0.26. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44. The company has a 50-day simple moving average of $9.80 and a two-hundred day simple moving average of $8.89. Haleon plc has a 12-month low of $7.70 and a 12-month high of $10.76.

Haleon (NYSE:HLN - Get Free Report) last announced its quarterly earnings data on Thursday, August 1st. The company reported $0.08 earnings per share for the quarter, missing analysts' consensus estimates of $0.09 by ($0.01). Haleon had a net margin of 9.71% and a return on equity of 13.15%. The business had revenue of $3.50 billion during the quarter, compared to analyst estimates of $3.55 billion. During the same quarter last year, the firm posted $0.08 EPS. Research analysts expect that Haleon plc will post 0.46 earnings per share for the current fiscal year.

Haleon Cuts Dividend

The company also recently declared a semi-annual dividend, which was paid on Thursday, September 19th. Shareholders of record on Friday, August 16th were issued a dividend of $0.0514 per share. This represents a yield of 1.6%. The ex-dividend date of this dividend was Friday, August 16th. Haleon's dividend payout ratio (DPR) is presently 33.33%.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.